Top compounds associated with response to VN1R2


Feature Type Standardized
Nominal ANOVA
mRNA CX-5461 GDSC1000 pan-cancer AAC 0.023 0.5
mRNA XMD14-99 GDSC1000 pan-cancer AAC 0.024 0.5
mRNA CIL41 CTRPv2 pan-cancer AAC 0.038 0.5
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.024 0.5
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.023 0.5
mRNA BRD-K66453893 CTRPv2 pan-cancer AAC -0.022 0.5
mRNA regorafenib CTRPv2 pan-cancer AAC -0.026 0.5
mRNA masitinib CTRPv2 pan-cancer AAC -0.025 0.5
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.024 0.5
mRNA lenalidomide GDSC1000 pan-cancer AAC -0.025 0.5
Download CSV